HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
TLPH
Talphera, Inc.
There isn't enough reported data to score TLPH yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
TLPH Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Unavailable | |
| Unavailable |
TLPH's revenue and profitability are currently under pressure. There isn't enough data to rate its cash flow and balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
TLPH PE Valuation
TLPH has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
TLPH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| -- | |
| Limited | |
| High |
Analysts expect TLPH's losses to shrink, with revenue holding steady.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
TLPH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.24 | +$0.13 |
| Q2 2026 | -$0.30 | +$0.09 |
| Q1 2026 | -$0.34 | +$0.10 |
| Q4 2025 | -$0.40 | +$0.10 |
| Q3 2025 | -$0.37 | +$0.34 |
| Q2 2025 | -$0.39 | +$0.27 |
| Q1 2025 | -$0.44 | +$0.47 |
| Q4 2024 | -$0.50 | +$1.00 |
TLPH has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over TLPH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
TLPH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $281K | +12% |
| Q3 2023 | $117K | -77% |
| Q2 2023 | $253K | -56% |
| Q4 2022 | $252K | +12500% |
| Q3 2022 | $507K | -73% |
| Q2 2022 | $570K | +29% |
| Q1 2022 | $442K | -14% |
| Q4 2021 | $2K | -100% |
TLPH's revenue has slid since its 2020 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2025 | -342200% | N/A |
| Q1 2025 | -10800% | N/A |
| Q4 2023 | -1524% | +1425 points |
| Q3 2023 | -2828% | -1520 points |
| Q2 2023 | -1569% | +813 points |
| Q4 2022 | -2950% | +405800 points |
| Q3 2022 | -1308% | -844 points |
| Q2 2022 | -2381% | -121 points |
TLPH's operating margin was −342200% last quarter, down 340631 points from the same quarter a year ago, near the bottom of its range since 2019.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over TLPH on cash generation, producing positive trailing cash flow while its opponent burns cash.
TLPH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3M | -$524K |
| Q2 2026 | -$3.9M | -$976K |
| Q1 2026 | -$3.4M | +$70K |
| Q4 2025 | -$2.4M | -$182K |
| Q3 2025 | -$2.5M | +$426K |
| Q2 2025 | -$2.9M | +$1.7M |
| Q1 2025 | -$3.5M | -$587K |
| Q4 2024 | -$2.3M | +$1.7M |
TLPH has burned cash in almost every quarter: −$13M over the past year, against −$11M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over TLPH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
TLPH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +17.1K shares |
| 1 year | +82% | +34.1M shares |
| 3 years | +592% | +64.6M shares |
| 5 years | +1234% | +69.9M shares |
| Available history | +1808% | +71.6M shares |
TLPH has 76M diluted shares, up 82% from a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
TLPH Net Leverage
TLPH's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
TLPH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.1 | Neutral |
| Stochastic | 5.7 | Oversold |
TLPH's weekly RSI is 46 (neutral) and its Stochastic is 6 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
TLPH PE vs Healthcare Sector
| Metric | TLPH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
TLPH has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
TLPH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.08 | 4.6% below |
| 20 week MA | $1.19 | 13% below |
| 50 week MA | $1.03 | 0% above |
| 100 week MA | $0.85 | 21% above |
| 200 week MA | $0.91 | 13% above |
TLPH has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
TLPH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $44.8 | $25.4 | -43% |
| 2021 | $25.4 | $11.2 | -56% |
| 2022 | $11.2 | $2.07 | -82% |
| 2023 | $2.07 | $0.74 | -64% |
| 2024 | $0.74 | $0.53 | -28% |
| 2025 | $0.53 | $1.10 | +108% |
| 2026 YTD | $1.10 | $1.03 | -6.4% |
TLPH has the edge over HIMS on returns for 2026, with the stronger performance.